Skip to content

Clinical trials

Phase 3 Multiple Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 3 Country / region: United States Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20041
20054
20065
200711
20087
20096
20102
20114
20122
20136
20143
20156
20164
20175
20185
20194
20206
20214
20221
20232
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated13
Active, not recruiting8
Recruiting5
Unknown status2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen18
Novartis Pharmaceuticals8
Sanofi7
Acorda Therapeutics6
Celgene4
EMD Serono4
Genzyme, a Sanofi Company4
RVL Pharmaceuticals, Inc.4
Teva Branded Pharmaceutical Products R&D, Inc.4
Actelion3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis102
Multiple Sclerosis, Relapsing-Remitting24
Recurrence9
Muscle Spasticity8
Multiple Sclerosis, Chronic Progressive5
Demyelinating Diseases4
Amyotrophic Lateral Sclerosis2
Fatigue2
Optic Neuritis2
Autoimmune Diseases1

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.